מאמר משנת 2006 המראה כי חלה ירידה בקצב גילוי מקרי אוטיזם בעקבות הפסקת השימוש בתמירוסל כחומר משמר בחיסונים. מאז חלה הרעה נוספת עקב החזרת התימרוסל בחיסונים נגד שפעת הניתנים לילדים רבים מדי שנה.
תקציר ותרגום ע”י אומגה 3 גליל. למאמר המלא
Early Downward Trends in
Neurodevelopmental Disorders Following Removal
of Thimerosal-Containing Vaccines
David A. Geier, B.A. Mark R. Geier, M.D., Ph.D
Contemporaneously with the epidemic rise in neurodevelopmental disorders (NDs), first observed in the United States during the 1990s, the childhood immunization schedule was expanded by the U.S. Centers for Disease Control and Prevention (CDC) to include several additional thimerosal-containing vaccines (TCVs). On July 7, 1999, a joint recommendation was made by the American Academy of Pediatrics (AAP) and the U.S. Public Health Service (PHS) to remove thimerosal from vaccines. A two-phase study was undertaken to evaluate trends in diagnosis of new NDs entered into the Vaccine Adverse Event Reporting System (VAERS) and the California Department of Developmental Services (CDDS) databases on a reporting quarter basis, from 1994 through 2005. Significant increasing trends in newly diagnosed NDs were observed in both databases 1994 through mid-2002. Significant decreasing trends in newly diagnosed NDs were observed in both databases from mid-2002 through 2005. The results indicate that the trends in newly diagnosed NDs correspond directly to the expansion and subsequent contraction of the cumulative mercury dose to which children were exposed from TCVs through the U.S. immunization schedule.